NASDAQ:GENE Genetic Technologies - GENE News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Genetic Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. $1.10 0.00 (0.00%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.07▼$1.1150-Day Range$0.86▼$1.8252-Week Range$0.83▼$2.40Volume38,043 shsAverage Volume2.44 million shsMarket Capitalization$21.16 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Get Genetic Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for GENE and its competitors with MarketBeat's FREE daily newsletter. Email Address GENE Media Mentions By Week GENE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GENE News Sentiment▼0.000.49▲Average Medical News Sentiment GENE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GENE Articles This Week▼20▲GENE Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGenetic Technologies (NASDAQ:GENE) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - March 18 at 10:54 AMBack-to-back Studies Validate geneType Breast Cancer Risk Testfinance.yahoo.com - March 13 at 9:53 AMPreimplantation Genetic Testing Market Value To Top Us$ 1.4 Billion By 2032 : Fact.MR Studybenzinga.com - March 9 at 4:59 PMDecoding genetic technologiesmsn.com - February 27 at 6:22 PMGenetic Technologies Announces Closing of $5 Million Registered Direct Offeringfinance.yahoo.com - February 7 at 1:34 PMGenetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancerfinance.yahoo.com - February 6 at 9:29 AMWhy Genetic Technologies Shares Are Skyrocketing During Premarket Sessionmsn.com - February 3 at 10:10 AMGenetic Technologies Announces $5 Million Registered Direct Offeringfinance.yahoo.com - February 3 at 10:10 AMGenetic Technologies Shares Rise 8% After Qiagen Partnershipmarketwatch.com - February 1 at 3:45 PMGTG to form Strategic Alliance with global testing leader QIAGENfinance.yahoo.com - February 1 at 8:57 AMIndia says GM technology important for food security, import reductionmsn.com - December 8 at 7:33 AMSyncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporationfinance.yahoo.com - December 1 at 5:22 PMSyncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporationfinance.yahoo.com - November 29 at 8:51 AMSHAREHOLDER ALERT: Weiss Law Investigates Applied Genetic Technologies Corporationbenzinga.com - November 15 at 5:45 AM‘As Gods’ Review: Genetic Technology’s Human Revolutionwsj.com - November 11 at 1:42 PMWebinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious diseasefinance.yahoo.com - November 10 at 12:29 PMGenetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Preventionfinance.yahoo.com - November 9 at 11:35 AMSequencing.com Raises $5 Million In Venture Capital to Fund Groundbreaking DTC DNA Technologybenzinga.com - November 8 at 7:58 PMGenetic Technologies’ breast screening tech 9x more sensitive than current screeningproactiveinvestors.com - October 27 at 10:42 PMGenetic Technologies Announces Q1 FY23 Quarterly Results; Q1 Sales Of A$1.93M An Increase Of 375% From Q1 FY22benzinga.com - October 25 at 1:25 PMGenetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Detailsfinance.yahoo.com - October 25 at 1:25 PMWhat 5 Analyst Ratings Have To Say About Applied Genetic Techsmarkets.businessinsider.com - October 25 at 3:24 AMApplied Genetic Tech Shares Leap Premarket on Syncona Deal >AGTCmarketwatch.com - October 24 at 6:44 AMGenetic Engineering Market Size Worth USD 5811 Million by 2030 at 24.20% CAGR - Report by Market Research Future (MRFR)benzinga.com - October 15 at 12:44 PMGenetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Reportfinanznachrichten.de - October 13 at 3:24 PMGenetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)finance.yahoo.com - October 13 at 10:23 AMExpert Ratings for Applied Geneticmarkets.businessinsider.com - October 4 at 7:03 PMJournal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancerfinance.yahoo.com - September 29 at 10:02 AMDirect-To-Consumer (DTC) Genetic Testing Market Size to Grow at 15.53% CAGR During the Forecast Period of 2022-2027 | 119 Report Pagesmarketwatch.com - September 28 at 1:46 AMEurofins Genoma Announces Launch of niPGT-A, a Non-Invasive, Embryo Biopsy Free, Preimplantation Genetic Aneuploidy Screening Testfinance.yahoo.com - September 28 at 1:46 AMCalifornia man convicted of two decades-old murders with investigative genetic technologymsn.com - August 19 at 9:56 AMIDIBAPS Researchers Discover Genetic Drivers of Clonal Evolution in Leukemia Using Single-Cell DNA Sequencing from Mission Biomarkets.businessinsider.com - August 11 at 2:47 PMGeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physiciansfinance.yahoo.com - July 18 at 11:33 AMGeorge Church startup Manifold Bio raises $40m for ‘protein barcoding’ technology to improve drug testingmsn.com - July 14 at 3:06 PMManifold Bio raises $40m for ‘protein barcoding’ technology to make drug testing in animals more efficientmsn.com - July 14 at 10:06 AMCompletion of AffinityDNA Acquisition expanding global direct-to-consumer businessfinance.yahoo.com - July 14 at 10:06 AMGeneType Risk Assessment Test onboarding in 16 clinicsfinance.yahoo.com - July 1 at 9:37 AMApplied Genetic's Vision Loss Gene Therapy Shows Encouraging Safety, Efficacy At Three Monthsfinance.yahoo.com - May 17 at 11:25 AMJonBenet Ramsey’s dad bashes Colorado cops for refusing to use ‘modern technology’nypost.com - May 4 at 7:59 PMGenetic Technologies reports 9M resultsseekingalpha.com - April 8 at 12:43 PMMid-Afternoon Market Update: HireRight Rises Following Q4 Results; Applied Genetic Technologies Shares Fallmarkets.businessinsider.com - March 22 at 3:23 PMApplied Genetic Technologies plunges on $9.8M stock offeringseekingalpha.com - March 22 at 10:22 AMApplied Genetic Technologies proposes stock offering to fund clinical programs; slides 18%seekingalpha.com - March 21 at 7:08 PMUC Berkeley loses fight over rights to patent gene-editing technologymsn.com - March 1 at 9:48 PMUS Patent Office Grants Patent for COVID-19 Risk Testfinance.yahoo.com - February 23 at 9:00 AMASX Health Stocks: Genetic Tech gets lab certification, commences rollout of geneType Multi-Testmsn.com - February 20 at 11:03 PMApplied Genetic Q2 2022 Earnings Previewseekingalpha.com - February 11 at 11:51 AMGenetic Technologies reports FQ2 cash flow resultsseekingalpha.com - January 19 at 7:31 PMGenetic Technologies Reports Q2 FY22 Cash Flow Resultsfinance.yahoo.com - January 19 at 9:30 AMApplied Genetic exceeds enrollment target in AGTC-501 trial for vision lossseekingalpha.com - January 11 at 12:00 PM Get Genetic Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for GENE and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:GENE) was last updated on 3/24/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.